In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.
Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
Kirsten Axelsen, Rachel Portman, and Jae Kim of DLA Piper discuss clinical trial complexities, FDA guidance, and innovative designs with Adam Donat of Quest Diagnostics in an interview.
19 May 2023
Life sciences companies and the risks posed by the mifepristone litigation
FDA regulatory lawyers and life sciences litigators analyze the mifepristone litigation, focusing on citizen petitions and FDA approvals, in order to inform manufacturers' strategies; this is an interview.
12 Apr 2023
Trade secrets protection in the life sciences sector
Roberto Valenti and Ray Miller of DLA Piper examine trade secret protection for pharmaceutical and medical device companies in the US and Europe, offering practical management approaches in this interview.
6 Feb 2023
Cross-border considerations for privacy in clinical trials
James Clark, Paula Gonzalez de Castejón, and David Kopans examine EU and US perspectives on privacy considerations for cross-border clinical trials in this interview.
3 Nov 2022
Global Life Sciences Supply Chain Insights
Lauren Murdza and Richard Taylor discuss critical supply chain challenges impacting the global life sciences sector, offering listeners valuable insights into industry best practices in this interview.
6 Sept 2022
AI risk assessments: Future-proofing your innovation when rules can change mid-game
Aviva Wein, Assistant General Counsel at Johnson & Johnson, and Danny Tobey, DLA Piper partner, examine how medical device and pharmaceutical companies prepare for evolving AI regulations, in this interview.
1 Jun 2022
The rise of global telehealth
Kristi Kung and Greg Bodulovic examine telehealth's expansion during the pandemic and technological innovations striving to equalize global healthcare access in this interview episode.
18 Apr 2022
Advising the advisor: Tips for navigating the life sciences and regulatory environment
Kevin Sheridan explores how advisors in public offerings and M&A transactions benefit from understanding the life sciences industry, in conversation with Emilio Ragosa.
21 Mar 2022
The moral imperative: Balancing innovation, regulation and prescription drug availability
Peter Kolchinsky discusses balancing biopharmaceutical innovation, industry regulations, and prescription drug availability with Jim Greenwood and Geoff Levitt in this interview.
2 Mar 2022
Incentivizing diverse representation in clinical trials
Shazia Ahmad discusses with Kirsten Axelsen and Sarah Schick the crucial role of regulatory incentives in boosting racial and ethnic diversity within clinical trials, ultimately leading to improved healthcare outcomes in this interview.
16 Dec 2021
The crossroad of science and law
Michael King discusses the advantages of scientific expertise in legal disputes with Lucas Przymusinski and Raymond Williams, highlighting its impact on litigation strategies in this interview.
8 Nov 2021
Social media’s impact on the life sciences industry
Sarah Heineman of Bayer explores social media's influence on public perception of medicine and science with Chris Campbell and Jody Rhodes of DLA Piper in this interview.
5 Oct 2021
Understanding AI and its use in drug discovery
Duane Valz explores artificial intelligence applications in drug discovery with Ellen Scordino and Susan Krumplitsch, revealing how machine learning accelerates medicine development in this interview episode.
3 Sept 2021
mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando
Kathy Fernando, Pfizer's Head Vice President, discusses mRNA technology and its application in the COVID-19 vaccine, highlighting the scientific advancements that made rapid vaccine development possible in this interview.
Who has been a guest on At the Intersection of Science and Law
Names identified in recent episode analyses. Showing up to five guests.
Roberto Valenti
Ray Miller
James Clark
Paula Gonzalez de Castejón
David Kopans
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
2 ratings
Contact At the Intersection of Science and Law
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of At the Intersection of Science and Law?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
